Fasting Plasma Glucose and Risk of Incident Ischemic Stroke or Transient Ischemic Attacks
- 1 October 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (10) , 2351-2355
- https://doi.org/10.1161/01.str.0000140738.94047.55
Abstract
Background and Purpose— Diabetes and impaired fasting glucose are diagnosed based on an elevated plasma glucose level after an overnight fast. The diagnostic cutpoint of diabetes arises from the threshold for development of microvascular complications. Our aim was to examine the associations between clinical relevant categories of fasting glucose levels and the risk of incident ischemic stroke. Methods— Patients with documented coronary heart disease who were screened for inclusion in a secondary prevention clinical trial (n=13 999) were followed-up. At baseline, medical histories were obtained and plasma glucose and lipids assessed at a central study laboratory. During a 6- to 8-year follow-up period 1037 cases were identified with ischemic cerebrovascular disease, of which, after reviewing hospital records with diagnoses of cerebrovascular disease, 576 cases were verified to have had ischemic stroke or transient ischemic attacks. Results— Increasing fasting glucose level categories were positively associated with increasing age, male gender, body mass index, hypertension, total cholesterol, and triglycerides, and were inversely associated with high-density lipoprotein cholesterol and percent high-density lipoprotein of total cholesterol. In comparison with patients with fasting glucose levels of 90 to 99 mg/dL (n=3706) who constitute the largest category, the odds ratios of ischemic cerebrovascular disease, adjusting for potential confounders, were 1.47 (95% CI, 1.07 to 2.02) for fasting glucose 140 mg/dL. Similar J-shaped associations were observed in analysis excluding patients with known diagnosis of diabetes mellitus. Conclusions— The association between fasting plasma glucose and incident ischemic cerebrovascular events in patients with pre-existing atherothrombotic disease is J-shaped. Rates increase for fasting plasma glucose levels >100 mg/dL and also for those with low fasting glucose levels. These findings may carry important implications for prevention strategies.Keywords
This publication has 14 references indexed in Scilit:
- Follow-up Report on the Diagnosis of Diabetes MellitusDiabetes Care, 2003
- Is the Current Definition for Diabetes Relevant to Mortality Risk From All Causes and Cardiovascular and Noncardiovascular Diseases?Diabetes Care, 2003
- Dietary Prescriptions to Control DyslipidemiasCirculation, 2002
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001
- Effects of insulin per se on neuroendocrine and metabolic counter-regulatory responses to hypoglycaemiaClinical Science, 2000
- Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes.Diabetes Care, 2000
- Risk Factors for Stroke in Type 2 Diabetes MellitusArchives of internal medicine (1960), 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998